JP Morgan Chase
ELOS

JP Morgan Chase’s Syneron Medical Ltd ELOS Stock Holding History

JP Morgan Chase’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,601
Closed -$182K – 5397
2017
Q2 		$182K Buy
+16,601
New +$182K ﹤0.01% 4012
2017
Q1 		– Sell
-5,540
Closed -$47K – 5376
2016
Q4 		$47K Sell
5,540
-6,923
-56% -$54.3K ﹤0.01% 4575
2016
Q3 		$89K Sell
12,463
-2,614,519
-100% -$18.2M ﹤0.01% 3894
2016
Q2 		$20.2M Sell
2,626,982
-38,171
-1% -$272K 0.01% 1389
2016
Q1 		$19.5M Sell
2,665,153
-173,968
-6% -$1.25M 0.01% 1355
2015
Q4 		$21.9M Buy
2,839,121
+28,751
+1% +$219K 0.01% 1262
2015
Q3 		$20.1M Sell
2,810,370
-110,630
-4% -$1.06M 0.01% 1253
2015
Q2 		$31M Buy
2,921,000
+22,101
+0.8% +$259K 0.01% 1147
2015
Q1 		$35.9M Buy
2,898,899
+822,245
+40% +$9.1M 0.01% 1058
2014
Q4 		$19.4M Sell
2,076,654
-180,273
-8% -$1.74M ﹤0.01% 1492
2014
Q3 		$22.6M Sell
2,256,927
-24,874
-1% -$253K 0.01% 1372
2014
Q2 		$23.5M Sell
2,281,801
-164,595
-7% -$1.78M 0.01% 1241
2014
Q1 		$30.5M Buy
2,446,396
+45,739
+2% +$542K 0.01% 1089
2013
Q4 		$29.5M Sell
2,400,657
-4,320
-0.2% -$44.9K 0.01% 1089
2013
Q3 		$20.7M Sell
2,404,977
-1,100
-0% -$9.49K 0.01% 1306
2013
Q2 		$20.9M Buy
+2,406,077
New +$21.5M 0.01% 1223

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

JP Morgan Chase's ELOS Position: Q3 2017 in Review

JP Morgan Chase sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 16,601 shares — an estimated $182K sold.

JP Morgan Chase first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $35.9M in Q1 2015. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • JP Morgan Chase reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • JP Morgan Chase sold 16,601 Syneron Medical Ltd shares in Q3 2017, an estimated $182K.
  • JP Morgan Chase first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
  • JP Morgan Chase's Syneron Medical Ltd position peaked at $35.9M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.